{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:19:36Z","timestamp":1765369176309},"reference-count":16,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T00:00:00Z","timestamp":1488412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"None"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Interven Cardiology"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study sought to identify patient and left atrial morphology specific factors associated with early complications for left atrial appendage occlusion with the Watchman\u2122 (Boston Scientific, Natick, MA) device.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Oral anticoagulation (OAC) is recommended for patients with atrial fibrillation, however, long\u2010term OAC compliance is poor. In randomized control trials, the Watchman\u2122 device has demonstrated superiority over OAC with warfarin for all cause and cardiovascular mortality and hemorrhagic stroke. However, predictors of procedural complications have not yet been well established.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>There were 137 patients included in this study from a total of 141 consecutive patients prospectively enrolled in the registry between 8\/1\/2015 and 08\/31\/2016. Unadjusted, multivariate cox proportional hazards model was used for analysis. Primary end\u2010point was a composite major adverse cardiac and cerebrovascular event (MACCE) defined to include death, stroke, major and life threatening bleeding, major vascular complications, device embolization, need for cardiovascular surgery, need for cardiopulmonary resuscitation, and significant pericardial effusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The primary endpoint was reached in 5.8% of patients. There were no device embolization and no strokes. Anterior chicken morphology (ACW) of the left atrial appendage (LAA) conferred a hazard ratio of 3.7 for MACCE and a body mass index &gt;30\u2009kg\/m<jats:sup>2<\/jats:sup> significantly lowered the likelihood of a MACCE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Certain LAA morphologies and patient characteristics increase the risk for a MACCE following left atrial appendage occlusion (LAAO) with the Watchman\u2122 device. Anterior chicken wing morphology of the LAA and low BMI &lt;30\u2009kg\/m<jats:sup>2<\/jats:sup> were independent predictors of MACCE in the multivariate regression model.<\/jats:p><\/jats:sec>","DOI":"10.1111\/joic.12374","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T02:52:42Z","timestamp":1488509562000},"page":"163-169","source":"Crossref","is-referenced-by-count":13,"title":["Left atrial anatomy and patient\u2010related factors associated with adverse outcomes with the watchman device\u2014a real world experience"],"prefix":"10.1111","volume":"30","author":[{"given":"Shishir","family":"Murarka","sequence":"first","affiliation":[{"name":"Division of Interventional Cardiology University of Arizona at Banner University Medical Center Phoenix Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Lazkani","sequence":"additional","affiliation":[{"name":"Division of Interventional Cardiology University of Arizona at Banner University Medical Center Phoenix Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soundos","family":"Moualla","sequence":"additional","affiliation":[{"name":"Division of Interventional Cardiology University of Arizona at Banner University Medical Center Phoenix Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya Ratan","family":"Verma","sequence":"additional","affiliation":[{"name":"Division of Interventional Cardiology University of Arizona at Banner University Medical Center Phoenix Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Pershad","sequence":"additional","affiliation":[{"name":"Division of Interventional Cardiology University of Arizona at Banner University Medical Center Phoenix Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009718"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00887-X"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs253"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15192"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.04.032"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2013.01.036"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.03.003"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.001"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.11.011"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv730"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.010"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.04.019"},{"key":"e_1_2_8_14_1","first-page":"3671","article-title":"The WATCHMAN left atrial appendage closure device for atrial fibrillation","volume":"60","author":"M\u00f6bius\u2010Winkler S","year":"2012","journal-title":"J Vis Exp"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY14M09_18"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0284185113507446"},{"key":"e_1_2_8_17_1","unstructured":"ClinicalTrials.govIdentifier: NCT02879448. AMPLATZER\u2122 Amulet\u2122 Left Atrial Appendage Occluder Randomized Controlled Trial."}],"container-title":["Journal of Interventional Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjoic.12374","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joic.12374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T05:53:42Z","timestamp":1696485222000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joic.12374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/joic.12374"],"URL":"https:\/\/doi.org\/10.1111\/joic.12374","archive":["Portico"],"relation":{},"ISSN":["0896-4327","1540-8183"],"issn-type":[{"value":"0896-4327","type":"print"},{"value":"1540-8183","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}